Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-22-003399
Filing Date
2022-06-24
Accepted
2022-06-24 16:15:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 ADAGIO THERAPEUTICS, INC. p22-1704sc13da.htm SC 13D/A 50089
  Complete submission text file 0000902664-22-003399.txt   51597
Mailing Address 700 CANAL STREET, 2ND FLOOR STAMFORD CT 06902
Business Address 700 CANAL STREET, 2ND FLOOR STAMFORD CT 06902 203-516-3730
M28 Capital Management LP (Filed by) CIK: 0001807489 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Subject) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92804 | Film No.: 221040284
SIC: 2836 Biological Products, (No Diagnostic Substances)